LATEST PUBLICATIONS

META-CANFollow

📌@aromicsbiotech, among the 175+ European companies that will present its advances in the 3th edition of @TechTourHQ Contest Final to an international audience of 350+investors, key corporates &innovation experts ▶️https://t.co/hy204evuZG

#TTFinal19 #BermesProject

Reply on Twitter Retweet on Twitter2 Like on Twitter7 Twitter

META-CAN @meta_canproject·

2 Dec

The new MetaboList :)

Reply on Twitter Retweet on Twitter Like on Twitter4 Twitter

Retweet on Twitter META-CAN Retweeted

Powell Lab @J_Powell_Lab·

27 Nov

fantastic work in @sciencemagazine from our own @bobdleone about glutamine antagonism in cancer. double-edged sword that suppresses tumor metabolism and increases functionality of the TIL. #immunotherapy #immunometabolism

Reply on Twitter Retweet on Twitter13 Like on Twitter27 Twitter

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.

About us

The project

Bellvitge Biomedical
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat
Barcelona, Spain